Annexa Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Port Melbourne, VIC Australia
Total Funding:N/A
Industry:Tech Services
Founded:1994
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Annexa's estimated annual revenue is currently $6.2M per year.
  • Annexa's estimated revenue per employee is $145,000

Employee Data

  • Annexa has 43 Employees.
  • Annexa grew their employee count by 34% last year.
  • Annexa currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$26.8M185N/AN/A-N/A
#2
$13.3M9223%N/A4.6/5N/A
#3
$134.4M9275%N/A-N/A
#4
$1.2M8N/AN/A4.5/5N/A
#5
$13.5M9331%N/A4.7/5N/A
#6
$4.6M32N/AN/A5/5N/A
#7
$13.3M9230%N/A-N/A
#8
$6.5M45N/AN/A5/5N/A
#9
$20M138N/AN/A-N/A
#10
$0.9M6N/AN/A4.5/5N/A
Missing a competitor? Contribute!?
Submit

We are a leading business systems solution provider and NetSuite Partner. We work with forward-thinking Australian companies ready to take their business systems to the next level. As 5 Star NetSuite Partners we are well-versed in the design and implementation of revolutionary cloud technology geared towards promoting business growth and sustainability. Wherever your business is heading, we bring the new thinking, new systems and new innovation needed to get you there. If your company is driven to innovate, enlisting our passion and talent will create the strong, enduring partnership needed to realise your vision. With in-house NetSuite experts adept at helping businesses navigate the latest technologies we help identify business challenges, develop solutions, implement systems and provide ongoing support, ensuring business growth and sustainable change. If you're ready to start the ERP journey, reach out to our experts: 1300 994 550 sales@annexa.com.au Head office: Level 1, 289 Ingles St, Port Melbourne 3207 Sydney Office: Shop 1, 35 Buckingham St, Surry Hills, Sydney 2010

keywords:N/A

43

Number of Employees

$6.2M

Revenue (est)

1

Current Jobs

34%

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Annexa News

1-Mar-19 - European CHMP Adopts Positive Opinion on Ondexxya™ (andexanet

The MAA submission is based on data from two Phase 3 ANNEXA studies that evaluated the safety and efficacy of Ondexxya in reversing the

12-Mar-19 - Highlights from ISC: Use of opioids, e-cigarettes, alcohol may

ANNEXA-4: Andexanet alfa successfully reverses factor Xa inhibitor effects. Andexanet alfa reversed the anticoagulation effects of factor Xa

}